The production of antibody drugs involves complex processes. From cell line establishment to process scale-up, quality control at each step critically impacts product safety. To ensure antibody drug safety, it is essential to establish rigorous biosafety evaluation systems, employ advanced detection technologies, and continuously optimize quality control strategies.
